US stocks plummet as tariff tensions with China rise, Japan warns of potential harm from proposed duties, and AVI urges Rohto to scale back regenerative medicine.
What is covered in the Full Insight:
Market Overview
US-Japan Tariff Talks
Performance of Japanese Companies
Economic Concerns
Global Industry Risks
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.